Osteoarthritis and Diabetes: Where Are We and Where Should We Go?

被引:12
|
作者
Alenazi, Aqeel M. [1 ]
Alhowimel, Ahmed S. [1 ]
Alshehri, Mohammed M. [2 ]
Alqahtani, Bader A. [1 ]
Alhwoaimel, Norah A. [1 ]
Segal, Neil A. [3 ]
Kluding, Patricia M. [4 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Dept Hlth & Rehabil Sci, Alkharj 11942, Saudi Arabia
[2] Jazan Univ, Dept Phys Therapy, Jazan 45142, Saudi Arabia
[3] Univ Kansas, Dept Phys Med & Rehabil, Med Ctr, Kansas City, KS 66160 USA
[4] Univ Kansas, Dept Phys Therapy & Rehabil Sci, Med Ctr, Kansas City, KS 66160 USA
关键词
osteoarthritis; diabetics; high blood glucose; pain intensity; symptoms; gait; pace; RADIOGRAPHIC KNEE OSTEOARTHRITIS; EARLY POSTOPERATIVE OUTCOMES; CLINICALLY DIAGNOSED KNEE; HAND OSTEOARTHRITIS; RISK-FACTORS; METABOLIC SYNDROME; GENERALIZED OSTEOARTHRITIS; UNITED-STATES; WALKING SPEED; ASSOCIATION;
D O I
10.3390/diagnostics13081386
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus (DM) and osteoarthritis (OA) are chronic noncommunicable diseases that affect millions of people worldwide. OA and DM are prevalent worldwide and associated with chronic pain and disability. Evidence suggests that DM and OA coexist within the same population. The coexistence of DM in patients with OA has been linked to the development and progression of the disease. Furthermore, DM is associated with a greater degree of osteoarthritic pain. Numerous risk factors are common to both DM and OA. Age, sex, race, and metabolic diseases (e.g., obesity, hypertension, and dyslipidemia) have been identified as risk factors. These risk factors (demographics and metabolic disorder) are associated with DM or OA. Other possible factors may include sleep disorders and depression. Medications for metabolic syndromes might be related to the incidence and progression of OA, with conflicting results. Given the growing body of evidence indicating a relationship between DM and OA, it is vital to analyze, interpret, and integrate these findings. Therefore, the purpose of this review was to evaluate the evidence on the prevalence, relationship, pain, and risk factors of both DM and OA. The research was limited to knee, hip, and hand OA.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Pheochromocytoma – where are we? Where should we go? A medical and scientific odysseyReview
    Hartmut P. H. Neumann
    Giuseppe Opocher
    Andrzej Januszewicz
    Charis Eng
    Familial Cancer, 2005, 4 : 1 - 1
  • [42] Catfish Sampling Techniques: Where We Are Now and Where We Should Go
    Bodine, Kristopher A.
    Shoup, Daniel E.
    Olive, Jason
    Ford, Zachary L.
    Krogman, Rebecca
    Stubbs, Tyler J.
    FISHERIES, 2013, 38 (12) : 529 - 546
  • [43] Dissemination research in cancer control: where are we and where should we go?
    Deborah J. Bowen
    Glorian Sorensen
    Bryan J. Weiner
    Marci Campbell
    Karen Emmons
    Cathy Melvin
    Cancer Causes & Control, 2009, 20 : 473 - 485
  • [44] Digital human resource development: where are we? Where should we go and how do we go there?
    Thite, Mohan
    HUMAN RESOURCE DEVELOPMENT INTERNATIONAL, 2022, 25 (01) : 87 - 103
  • [45] Where we should be and where we are
    Corral De la Calle, M. A.
    RADIOLOGIA, 2010, 52 (03): : 193 - 195
  • [46] Child preference in custody decisions: Where we have been, where we are now, where we should go
    Nemechek, K
    IOWA LAW REVIEW, 1998, 83 (02) : 437 - 469
  • [47] Where Should We Go and How Should We Get There? Response
    Cohen, Eliot A.
    POLITICAL PSYCHOLOGY, 2018, 39 (05) : 1199 - 1200
  • [48] Melanoma: Where we are and where we go
    Mohammadpour, Ali
    Derakhshan, Maryam
    Darabi, Hassan
    Hedayat, Pegah
    Momeni, Mohammad
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) : 3307 - 3320
  • [49] Lead malfunctions in implantable cardioverter defibrillators: where are we and where should we go?
    Corrado, Andrea
    Gasparini, Gianni
    Raviele, Antonio
    EUROPACE, 2009, 11 (03): : 276 - 277
  • [50] Diversity, innovation and entrepreneurship: where are we and where should we go in future studies?
    Charlie Karlsson
    Jonna Rickardsson
    Joakim Wincent
    Small Business Economics, 2021, 56 : 759 - 772